Primary Breast Tumors Often Switch HER2 Status on Relapse Primary Breast Tumors Often Switch HER2 Status on Relapse

A substantial proportion of primary breast tumors switch from HER2-0 to HER2-low expression upon relapse, possibly widening the opportunity to treat patients with novel agents.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news